Becton Dickinson
- BDX
- NYSE
- Consumer Products
- Latest 100.83
- Currency US$
- Change 0.66
- Percent Change 0.659 %
- Volume 835,051
- Fri May 24, 2013 4:00 PM EDT NYSE data delayed 15 minutes.
The Globe and Mail
- Open 99.57
- Previous Close 100.17
- High 100.85
- Low 99.02
- Bidx0 --
- Askx0 103.34
- 52-week High 05/22 102.725
- 52-week Low 06/04 71.56
- Beta 0.835
- Market Cap 19,556.99M
- EPS 5.68
- P/E 17.75
- Forward P/E 16.107
- PEG 2.28
- Annual Dividend 1.98
- Yield 1.964
News
Financials & Calendars
- Sales $7,848,270,000
- Earnings $1,516,990,000
- Return on Equity 33.49%
- Cash Flow --
- Cash $2,023,860,000
- Current Ratio 2.93
12 months ended Mar 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
- Assets $11,629,920,000
- Liabilities $7,041,140,000
- Liabilities-to-Equity Ratio 1.53
Price Ratios
- Price to Sales 2.49
- Price to Book 4.26
- Price to Cash Flow n/a
Event Calendar
| Event | Last | Next | ||
|---|---|---|---|---|
| Earnings | May 2 | $1.35 | Aug 8 | $1.48 |
| Surprises | May 2 | 6.67% | n/a | n/a |
| Dividends | Mar 6 | $0.50 | n/a | n/a |
| Splits | n/a | -- | n/a | n/a |
12 months ended May 25, 2013.
A look at major corporate events and financial announcements that are coming up.
Company Information
About the Company
Becton, Dickinson and Co. is engaged principally in the manufacture and sale of a broad line of supplies, devices and systems used by health care professionals, medical research institutions and the general public. BD's operations consist of three worldwide business segments: Medical Systems, Biosciences, and Preanalytical Solutions.
Officers
- VINCENT A. FORLENZA Chairman; President;C.E.O;
- SUKETU UPADHYAY C.F.O. and Exec. V.P.
- Company Type: n/a
- Company Status: n/a
- Full-time Employees: n/a
-
Incorporation:
United States,
n/a -
Top 1000 Ranking:
Profit: n/a
Revenue: n/a
Assets: n/a
Ideas & Discussion
Live Discussion of BDX on StockTwits